Q: According to Portfolio Analytics, my current allocation to Health Care sector is too low. Here are the names of 12 major US pharmaceutical companies. How would you rank them? If possible, please provide a short comment on each of them: Pfizer, Johnson and Johnson, AbbVie, Amgen, Gilead Sciences, Eli Lilly, Merck, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Abbott, Biogen, Bristol Myers Squibbs. Thank you

Q: Repligen is trading close to the 52-week low and would welcome your analysis of their recent operating performance and market potential looking forward.  Post-pandemic and mindful of competitors in the same space does their stock have any opportunity to excel in the coming year, and if held as a position in a long-term growth portfolio, could you please rank the appeal of Repligen in descending order versus your go-to favorites in the same general space.  Thanks kindly for your thoughts.

Q: Hi 5i,

For Guardant Health (GH) would you recommend holding or selling at this time?

If selling is your recommendation please provide 5 US healthcare stocks that have good prospects in the near to long term.

Thank you.